Results 1 to 10 of about 102,559 (263)

Systemic immune-inflammation index is associated with hepatic steatosis: Evidence from NHANES 2015-2018

Frontiers in Immunology, 2022
BackgroundAs a novel inflammatory marker, Systemic Immune-Inflammation Index (SII) has not been studied with hepatic steatosis. The aim of this study was to investigate the possible relationship between SII and hepatic steatosis.MethodsIn the cross ...
Yancheng Song, Zhaopeng Li, Song Yancheng   +2 more
exaly   +3 more sources

Association of Hepatic Steatosis Index with Nonalcoholic Fatty Liver Disease Diagnosed by Non-Enhanced CT in a Screening Population

Diagnostics, 2021
The noninvasive diagnosis of hepatic steatosis is of increasing concern. This study investigated the association of hepatic steatosis determined by non-enhanced CT criteria with clinical parameters in a screening population.
Jieun Chung, Hee-Sun Park, Young-Jun Kim, Mi-Hye Yu, Sungeun Park, Sung-Il Jung   +5 more
exaly   +3 more sources

Anthelmintics nitazoxanide protects against experimental hyperlipidemia and hepatic steatosis in hamsters and mice

Acta Pharmaceutica Sinica B, 2022
Lipid metabolism disorders contribute to hyperlipidemia and hepatic steatosis. It is ideal to develop drugs simultaneous improving both hyperlipidemia and hepatic steatosis.
Fengfeng Li
exaly   +3 more sources

Cancer and hepatic steatosis [PDF]

ESMO Open, 2021
Non-alcoholic fatty liver disease (NAFLD) is a highly prevalent and increasing liver disease, which encompasses a variety of liver diseases of different severity. NAFLD can lead to liver cirrhosis with all its complications as well as hepatocellular carcinoma (HCC). Steatosis of the liver is not only related to obesity and other metabolic risk factors,
Paternostro, R., Sieghart, W., Trauner, M., Pinter, M.   +3 more
openaire   +2 more sources

Combined effect of serum carcinoembryonic antigen and hepatic steatosis on new-onset ischemic heart disease among middle-aged and older Korean adults: a cohort study

Frontiers in Nutrition, 2023
BackgroundCarcinoembryonic antigen (CEA) is a commonly used tumor marker in cancer screening. However, it has also been associated with metabolic alterations.
Ji Won Kwak, Yong Jae Lee, Byoungjin Park, Dong Hyuk Jung   +3 more
doaj   +1 more source

Hepatitis C and hepatic steatosis [PDF]

QJM, 2010
Hepatic steatosis is commonly seen in patients with chronic hepatitis C infection, and the two together have a greater association than by chance alone. Hepatitis C virus is closely associated with lipid metabolism throughout its lifecycle. Hepatic steatosis is more common in genotype 3 infection, due to direct viral effects including through ...
J H, Patel, J F L, Cobbold, H C, Thomas, S D, Taylor-Robinson   +3 more
openaire   +2 more sources

The Associations of Anthropometric Parameters and Hepatic Steatosis [PDF]

Journal of Fasting and Health, 2020
Introduction: Non-alcoholic fatty liver disease (NAFLD) is an important health problem globally that characterized as a disease spectrum which includes simple steatosis, non-alcoholic steatohepatitis and liver fibrosis and cirrhosis.
Maryam Ghandehari, Zahra Dehnavi, Farkhondeh Razmpour, Mahsa Miryan, Davood Soleimani, Seyed Mostafa Parizadeh, Reza Jafarzadeh Esfehani, Majid Sedaghat, Habibollah Esmaily, Mohsen Nematy   +9 more
doaj   +1 more source

Hepatic Steatosis Predicts Higher Incidence of Recurrence in Colorectal Cancer Liver Metastasis Patients

Frontiers in Oncology, 2021
Purpose: Colorectal liver metastasis (CRLM) is the major cause of death due to colorectal cancer. Although great efforts have been made in treatment of CRLM, about 60–70% of patients will develop hepatic recurrence.
Haiyan Chen, Haiyan Chen, Siqi Dai, Siqi Dai, Yimin Fang, Yimin Fang, Liubo Chen, Liubo Chen, Kai Jiang, Kai Jiang, Qichun Wei, Qichun Wei, Kefeng Ding, Kefeng Ding   +13 more
doaj   +1 more source

Comparison of 1H-magnetic resonance spectroscopy and blood biochemistry as methods for monitoring non-diffuse hepatic steatosis in a rat model

Toxicology Reports, 2023
No method of monitoring drug-induced hepatic steatosis has been established, which is a concern in drug development. Hepatic steatosis is divided into diffuse and non-diffuse forms according to the pattern of fat deposition. Diffuse hepatic steatosis was
Yuka Yoshino, Yuta Fujii, Kazuhiro Chihara, Aya Nakae, Jun-ichiro Enmi, Yoshichika Yoshioka, Izuru Miyawaki   +6 more
doaj   +1 more source

Steatosis and hepatitis C [PDF]

Gastroenterology Report, 2015
Hepatitis C virus (HCV) infection is a common liver disease worldwide with a high rate of chronicity (75-80%) in infected individuals. The chronic form of HCV leads to steatosis, cirrhosis and hepatocellualr carcinoma. Steatosis is prevalent in HCV patients (55%) due to a combination of viral factors (effect of viral proteins on some of the ...
Modaresi Esfeh, Jamak, Ansari-Gilani, Kianoush   +1 more
openaire   +2 more sources